Meet David Hysong -- 30 year old adenoid cystic carcinoma patient and CEO of SHEPHERD Therapeutics. Here's his remarkable story is below for consideration to pass along or speak with him about his journey: Hysong finished his master's degree in intellectual history in 2011 and found himself with a